A placebo-controlled, double-blind, multicentre phase III trial to assess the efficacy and safety of miltefosine solution in the treatment of breast cancer where no other appropriate treatment is available Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Sentinel lymph node biopsy feasibility study in patients with primary cutaneous melanoma http://cancerhelp.cancerresearchuk.org/trials/a-study-to-investigate-the-diagnosis-and-treatment-of-melanoma-skin-cancer-with-sentinel-lymph-node-biopsy

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

An investigation into the pathophysiology of breast cancer-related lymphoedema http://www.cancerresearchuk.org/cancer-help/trials/a-study-understand-more-about-breast-cancer-related-lymphoedema

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

British stomach cancer group trial IV: A randomised trial of cimetidine treatment in gastric cancer Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Development and evaluation of a training intervention for cancer teams talking about randomised trials http://www.cancerhelp.org.uk/trials/a-study-looking-at-peoples-attitudes-towards-clinical-trials-and-how-doctors-and-nurses-give-information-about-taking-part-in-a-trial

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

The role of radical surgery in advanced epithelial ovarian cancer Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A Cancer Research UK Randomised Multicentre Phase II Trial of the DNA-hypomethylating Agent, 5-Aza-2'-deoxycytidine(Decitabine) given intravenously in Combination with Carboplatin, versus Carboplatin alone given 4 weekly in patients with progressive, advanced Ovarian cancer To estimate the response rate of the combination of decitabine and carboplatin compared to carboplatin alone in patients with progressive advanced ovarian cancer who have previously responded to plati...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A randomised double-blind placebo-controlled cancer prevention trial with an estimated duration of 5 years and with 52,000 subjects recruited from the general populations of the UK, Denmark, Sweden, Finland and the United States Not provided at time of registration

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A trial looking at a new drug called AG-014699 for breast and ovarian cancer in people with gene faults 1) To determine whether AG-014699 has antitumour activity in locally advanced or metastatic breast and advanced ovarian cancer shown to express the BRCA 1 or 2 mutations 2) To evaulate the toxicit...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

SGI-110 with cisplatin and gemcitabine chemotherapy in patient with bladder cancer http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-sgi-110-with-cisplatin-and-gemcitabine-for-advanced-solid-tumours-spire

• Pays Aucun
• Organes Aucun
• Spécialités Aucune